Research map: Estimating the cost-effectiveness of tumor treating fields for locally advanced pancreatic cancer patients

Back to the article

Papers in this map

  1. Cancer statistics, 2023 · Rebecca L. Siegel · 2023 · 17047 citations · Cited by this paper
  2. Response to Kirshner et al.: updated cost consequence analyses using requested inputs · 2026 · Related
  3. Pancreatic Cancer · Wungki Park · 2021 · 1938 citations · Cited by this paper
  4. Clinical burden and healthcare resource utilization after allogeneic hematopoietic stem cell transplant for sickle cell disease or β-thalassemia · 2026 · Related
  5. Pancreatic cancer stroma: an update on therapeutic targeting strategies · Abdel Nasser Hosein · 2020 · 976 citations · Cited by this paper
  6. Cost-effectiveness of vagus nerve-mediated neuroimmune modulation for the treatment of moderate-to-severe rheumatoid arthritis · 2026 · Related
  7. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines · Marie Fallon · 2018 · 950 citations · Cited by this paper
  8. Interpreting per-death productivity estimates in human capital analyses of lung cancer: the role of working-age-restricted denominators · 2026 · Related
  9. An international survey of cancer pain characteristics and syndromes · Augusto Tommaso Caraceni · 1999 · 626 citations · Cited by this paper
  10. An unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma · 2026 · Related
  11. Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] · Darius Lakdawalla · 2018 · 549 citations · Cited by this paper
  12. Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis · 2026 · Related
  13. Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer · John H. Strickler · 2022 · 516 citations · Cited by this paper
  14. A system dynamics modelling protocol to evaluate the impact of a health financing mechanism for breast cancer pharmacotherapies in Malaysia · 2026 · Related
  15. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial · Zev A. Wainberg · 2023 · 505 citations · Cited by this paper
  16. The financial impact of surgical interventions for benign prostatic hyperplasia within a single NHS trust · 2026 · Related
  17. Pancreatic cancer · Thomas F. Stoop · 2025 · 456 citations · Cited by this paper
  18. From options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis · 2026 · Related
  19. Targeting hypoxic tumor microenvironment in pancreatic cancer · Jinxin Tao · 2021 · 416 citations · Cited by this paper
  20. Cost-effectiveness and budget impact of ezetimibe-atorvastatin single-pill combination versus free combination in Chinese adults with hypercholesterolemia · 2026 · Related
  21. Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer · Chiara Falcomatà · 2023 · 205 citations · Cited by this paper
  22. An Overview of Value, Perspective, and Decision Context—A Health Economics Approach: An ISPOR Special Task Force Report [2] · Louis P. Garrison · 2018 · 189 citations · Cited by this paper
  23. “The High Cost of Dying”: What Do the Data Show? · Anne A. Scitovsky · 2005 · 174 citations · Cited by this paper
  24. Cost-effectiveness Thresholds Used by Study Authors, 1990-2021 · Peter J. Neumann · 2023 · 171 citations · Cited by this paper
  25. Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now? · Beth S. Woods · 2020 · 159 citations · Cited by this paper
  26. Quality of Life in Patients With Pancreatic Cancer and Their Caregivers · Margaret R. Bauer · 2018 · 107 citations · Cited by this paper
  27. Anxiety, depression and quality of life in people with pancreatic cancer and their carers · Monika Janda · 2017 · 103 citations · Cited by this paper
  28. Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer · Eileen Mary O'Reilly · 2026 · 87 citations · Cited by this paper
  29. Pancreatic pain · Guralp Onur Ceyhan · 2008 · 81 citations · Cited by this paper
  30. Cost‐effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer · James Don Murphy · 2011 · 68 citations · Cited by this paper
  31. Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer · Brian Matthew Wolpin · 2026 · 64 citations · Cited by this paper
  32. Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study · Hani M. Babiker · 2025 · 47 citations · Cited by this paper
  33. Comparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-linenab-paclitaxel plus gemcitabine or FOLFIRINOX · George P. Kim · 2017 · 31 citations · Cited by this paper
  34. Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996–2030) · Igor Stukalin · 2021 · 28 citations · Cited by this paper
  35. Burden of Pancreatic Cancer and Disease Progression: Economic Analysis in the US · Stella Chang · 2006 · 25 citations · Cited by this paper
  36. Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000–2013 · Angela C. Tramontano · 2019 · 25 citations · Cited by this paper
  37. Economic evaluation for the UK of nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreas cancer · Mahdi Gharaibeh · 2015 · 21 citations · Cited by this paper
  38. Measuring the end-of-life premium in cancer using individual ex ante willingness to pay · Sara Olofsson · 2017 · 15 citations · Cited by this paper
  39. Cost-effectiveness of Gemcitabine Plus Modern Radiotherapy in Locally Advanced Pancreatic Cancer · Henry W. C. Leung · 2016 · 12 citations · Cited by this paper

Source: OpenAlex (CC0)